Elevance gains $190M on revised MA star ratings | Healthcare Dive
It’s a positive development for the insurer, which sued the government earlier this year after its quality scores fell dramatically.| Healthcare Dive
It’s a positive development for the insurer, which sued the government earlier this year after its quality scores fell dramatically.| Healthcare Dive
The payer is taking issue with how regulators calculated quality scores for 2024, after seeing a stars decline that could cause its bonus revenue to fall by $500 million.| Healthcare Dive
Friday’s district court ruling is the latest suggesting the CMS might have to recalculate every MA plan’s star rating score due to an administrative oversight.| Healthcare Dive
About 42% of Medicare Advantage plans that offer prescription drug coverage in 2024 earned four or more stars, compared with just over half this year.| Healthcare Dive
The payer lost 262,700 Medicaid members in the second quarter, dropping its total Medicaid lives to just over 16 million.| Healthcare Dive
The CMS proposed a 0.2% dip in MA rates. However, analysts said regulators will likely improve the payment rate in the final notice.| Healthcare Dive
UnitedHealth, CVS, Elevance and peers sidestepped the worst of medical cost growth in the quarter, but many payers face uncertainty from Medicare Advantage star ratings, GLP-1s and other pressures.| Healthcare Dive
Both hospital and payer groups came out in support of the rule finalized Wednesday, finding common ground in the need to streamline prior authorization.| Healthcare Dive
Despite heavy lobbying, insurers failed to see MA rates improve in the final rule, which codified a 0.16% decrease to benchmark funding.| Healthcare Dive
